Vioxx DTC Ads Consistent With “Learned Intermediary” Defense, Merck Says
Executive Summary
The extensive direct-to-consumer advertising for Vioxx will not undercut Merck's ability to assert a "learned intermediary" defense against personal injury claims, the company told analysts Dec. 14
You may also be interested in...
PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy
Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy
PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy
Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy
Merck Sets $604 Mil. Vioxx Legal Defense Reserve; PR Battles Continue
Merck will take a $604 mil. charge in the fourth quarter to establish a reserve for its defense of Vioxx litigation, an amount roughly equivalent to Singulair quarterly sales